Degradation of Newly Synthesized Polypeptides by Ribosome-Associated RACK1/c-Jun N-Terminal Kinase/Eukaryotic Elongation Factor 1A2 Complex

Molecular and Cellular Biology

Volumn 33, Issue 13, 2013, Pages 2510-2526

  Gandin, Valentina ^a,b   Gutierrez, Gustavo J ^c   Brill, Laurence M ^c   Varsano, Tal ^c   Feng, Yongmei ^c   Aza Blanc, Pedro ^c   Au, Qingyan ^c   McLaughlan, Shannon ^b   Ferreira, Tiago A ^d   Alain, Tommy ^a   Sonenberg, Nahum ^a   Topisirovic, Ivan ^b   Ronai, Ze'ev A ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Development and Aging Program Del E Webb Neuroscience Aging   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; EUKARYOTIC ELONGATION FACTOR 1A2; MITOGEN ACTIVATED PROTEIN KINASE P38; POLYPEPTIDE; RECEPTOR FOR ACTIVATED C KINASE 1; SERINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RIBOSOME; SMALL RIBOSOMAL SUBUNIT; STRESS;

ANIMALS; BASE SEQUENCE; CELL LINE; GTP-BINDING PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 7; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE ELONGATION FACTOR 1; PEPTIDES; PHOSPHORYLATION; POLYRIBOSOMES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; RECEPTORS, CELL SURFACE; RIBOSOMES; SERINE; SIGNAL TRANSDUCTION;

EID: 84880667395     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01362-12     Document Type: Article

References (62)

1. Kramer G, Boehringer D, Ban N, Bukau B. 2009. The ribosome as a platform for cotranslational processing, folding, and targeting of newly synthesized proteins. Nat. Struct. Mol. Biol. 16:589-597.
2. Jha S, Komar AA. 2011. Birth, life, and death of nascent polypeptide chains. Biotechnol. J. 6:623-640.
3. Brandt F, Carlson LA, Hartl FU, Baumeister W, Grunewald K. 2010. The three-dimensional organization of polyribosomes in intact human cells. Mol. Cell 39:560-569.
4. van den Berg B, Ellis RJ, Dobson CM. 1999. Effects of macromolecular crowding on protein folding and aggregation. EMBO J. 18:6927-6933.
5. Netzer WJ, Hartl FU. 1997. Recombination of protein domains facilitated by cotranslational folding in eukaryotes. Nature 388:343-349.
6. Nicola AV, Chen W, Helenius A. 1999. Cotranslational folding of an alphavirus capsid protein in the cytosol of living cells. Nat. Cell Biol. 1:341-345.
7. Sherman MY, Goldberg AL. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15-32.
8. Wiedmann B, Sakai H, Davis TA, Wiedmann M. 1994. A protein complex required for signal-sequence-specific sorting and translocation. Nature 370:434-440.
9. Hotokezaka Y, Tobben U, Hotokezaka H, Van Leyen K, Beatrix B, Smith DH, Nakamura T, Wiedmann M. 2002. Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides. J. Biol. Chem. 277:18545-18551.
10. Saito K, Kobayashi K, Wada M, Kikuno I, Takusagawa A, Mochizuki M, Uchiumi T, Ishitani R, Nureki O, Ito K. 2010. Omnipotent role of archaeal elongation factor 1α(EF1α) in translational elongation and termination, and quality control of protein synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:19242-19247.
11. Chuang SM, Chen L, Lambertson D, Anand M, Kinzy TG, Madura K. 2005. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol. Cell. Biol. 25:403-413.
12. Dimitrova LN, Kuroha K, Tatematsu T, Inada T. 2009. Nascent peptidedependent translation arrest leads to Not4p-mediated protein degradation by the proteasome. J. Biol. Chem. 284:10343-10352.
13. Nillegoda NB, Theodoraki MA, Mandal AK, Mayo KJ, Ren HY, Sultana R, Wu K, Johnson J, Cyr DM, Caplan AJ. 2010. Ubr1 and Ubr2 function in a quality control pathway for degradation of unfolded cytosolic proteins. Mol. Biol. Cell 21:2102-2116.
14. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774.
15. Turner GC, Varshavsky A. 2000. Detecting and measuring cotranslational protein degradation in vivo. Science 289:2117-2120.
16. Sha Z, Brill LM, Cabrera R, Kleifeld O, Scheliga JS, Glickman MH, Chang EC, Wolf DA. 2009. The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol. Cell 36:141-152.
17. Karin M. 1998. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851:139-146.
18. Gutierrez GJ, Tsuji T, Chen M, Jiang W, Ronai ZA. 2010. Interplay between Cdh1 and JNK activity during the cell cycle. Nat. Cell Biol. 12: 686-695.
19. Topisirovic I, Gutierrez GJ, Chen M, Appella E, Borden KL, Ronai ZA. 2009. Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl. Acad. Sci. U. S. A. 106:12676-12681.
20. Gandin V, Brina D, Marchisio PC, Biffo S. 2010. JNK inhibition arrests cotranslational degradation. Biochim. Biophys. Acta 1803:826-831.
21. Grosso S, Volta V, Vietri M, Gorrini C, Marchisio PC, Biffo S. 2008. Eukaryotic ribosomes host PKC activity. Biochem. Biophys. Res. Commun. 376:65-69.
22. Bhoumik A, Jones N, Ronai Z. 2004. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 101: 4222-4227.
23. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. 2008. Formation of stress granules inhibits apoptosis by suppressing stressresponsive MAPK pathways. Nat. Cell Biol. 10:1324-1332.
24. Gandin V, Miluzio A, Barbieri AM, Beugnet A, Kiyokawa H, Marchisio PC, Biffo S. 2008. Eukaryotic initiation factor 6 is rate-limiting in translation, growth, and transformation. Nature 455:684-688.
25. Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z. 2006. Regulation of p53 localization and activity by Ubc13. Mol. Cell. Biol. 26: 8901-8913.
26. Chamberlain JP. 1979. Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal. Biochem. 98:132-135.
27. Kieft JS, Zhou K, Jubin R, Doudna JA. 2001. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 7:194-206.
28. Grosso S, Volta V, Sala LA, Vietri M, Marchisio PC, Ron D, Biffo S. 2008. PKCβII modulates translation independently from mTOR and through RACK1. Biochem. J. 415:77-85.
29. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. 2005. RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19:309-320.
30. Werlen G, Jacinto E, Xia Y, Karin M. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101-3111.
31. Lopez-Bergami P, Ronai Z. 2008. Requirements for PKC-augmented JNK activation by MKK4/7. Int. J. Biochem. Cell Biol. 40:1055-1064.
32. Fuchs SY, Tappin I, Ronai Z. 2000. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation. J. Biol. Chem. 275:12560-12564.
33. Liu J, Lin A. 2005. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15:36-42.
34. Sengupta J, Nilsson J, Gursky R, Spahn CM, Nissen P, Frank J. 2004. Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat. Struct. Mol. Biol. 11:957-962.
35. Yu Y, Ji H, Doudna JA, Leary JA. 2005. Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes. Protein Sci. 14:1438-1446.
36. Coyle SM, Gilbert WV, Doudna JA. 2009. Direct link between RACK1 function and localization at the ribosome in vivo. Mol. Cell. Biol. 29: 1626-1634.
37. Wojtaszek PA, Heasley LE, Siriwardana G, Berl T. 1998. Dominantnegative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J. Biol. Chem. 273:800-804.
38. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
39. Wu S, Hu Y, Wang JL, Chatterjee M, Shi Y, Kaufman RJ. 2002. Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 277:18077-18083.
40. Rabl J, Leibundgut M, Ataide SF, Haag A, Ban N. 2011. Crystal structure of the eukaryotic 40S ribosomal subunit in complex with initiation factor 1. Science 331:730-736.
41. Mateyak MK, Kinzy TG. 2010. eEF1A: thinking outside the ribosome. J. Biol. Chem. 285:21209-21213.
42. Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell. Biol. 11:113-127.
43. Alkalaeva EZ, Pisarev AV, Frolova LY, Kisselev LL, Pestova TV. 2006. In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell 125:1125-1136.
44. Eggers DK, Welch WJ, Hansen WJ. 1997. Complexes between nascent polypeptides and their molecular chaperones in the cytosol of mammalian cells. Mol. Biol. Cell 8:1559-1573.
45. Perry RP, Kelley DE. 1968. Messenger RNA-protein complexes and newly synthesized ribosomal subunits: analysis of free particles and components of polyribosomes. J. Mol. Biol. 35:37-59.
46. Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9:537-549.
47. Rosenzweig R, Osmulski PA, Gaczynska M, Glickman MH. 2008. The central unit within the 19S regulatory particle of the proteasome. Nat. Struct. Mol. Biol. 15:573-580.
48. Ye Y, Meyer HH, Rapoport TA. 2001. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652-656.
49. Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S. 2002. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 22:626-634.
50. Kuroha K, Akamatsu M, Dimitrova L, Ito T, Kato Y, Shirahige K, Inada T. 2010. Receptor for activated C kinase 1 stimulates nascent polypeptidedependent translation arrest. EMBO Rep. 11:956-961.
51. Steitz TA. 2008. A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell. Biol. 9:242-253.
52. Hartl FU, Bracher A, Hayer-Hartl M. 2010. Molecular chaperones in protein folding and proteostasis. Nature 475:324-332.
53. Gonen H, Smith CE, Siegel NR, Kahana C, Merrick WC, Chakraburtty K, Schwartz AL, Ciechanover A. 1994. Protein synthesis elongation factor EF-1α is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc. Natl. Acad. Sci. U. S. A. 91:7648-7652.
54. Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R. 2008. Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene 27:7296-7306.
55. Yi CH, Pan H, Seebacher J, Jang IH, Hyberts SG, Heffron GJ, Vander Heiden MG, Yang R, Li F, Locasale JW, SharfiH, Zhai B, RodriguezMias R, Luithardt H, Cantley LC, Daley GQ, Asara JM, Gygi SP, Wagner G, Liu CF, Yuan J. 2011. Metabolic regulation of protein N-α-acetylation by Bcl-xL promotes cell survival. Cell 146:607-620.
56. Starheim KK, Arnesen T, Gromyko D, Ryningen A, Varhaug JE, Lille-haug JR. 2008. Identification of the human N(α)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression. Biochem. J. 415:325-331.
57. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM. 2002. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31:301-305.
58. Ruest LB, Marcotte R, Wang E. 2002. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J. Biol. Chem. 277:5418-5425.
59. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. 2007. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11: 447-460.
60. Kulkarni G, Turbin DA, Amiri A, Jeganathan S, Andrade-Navarro MA, Wu TD, Huntsman DG, Lee JM. 2007. Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res. Treat. 102:31-41.
61. Pinke DE, Kalloger SE, Francetic T, Huntsman DG, Lee JM. 2008. The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Gynecol. Oncol. 108:561-568.
62. Yam AY, Xia Y, Lin HT, Burlingame A, Gerstein M, Frydman J. 2008. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat. Struct. Mol. Biol. 15:1255-1262.